1. MicroRNAs as biomarker for breast cancer;Aggarwal;Endocr., Metab. Immune Disord.: Drug Targets,2020
2. Cancer and ongoing climate change: who are the most affected?;Yu;ACS Environ Au,2023
3. MicroRNAs as biomarker for breast cancer. Endocrine, metabolic & immune disorders-drug targets (formerly current drug targets-immune;Aggarwal;Endocrine & Metabolic Disorders),2020
4. ROR activation by Nobiletin enhances antitumor efficacy via suppression of IkappaB/NF-kappaB signaling in triple-negative breast cancer;Kim;Cell Death Dis.,2022
5. Metabolomics of breast cancer: a review;Subramani;Metabolites,2022